Litcius/Paper detail

Oncologists greet Lumakras: the world’s first KRAS inhibitor

Cormac Sheridan

2021Nature Biotechnology14 citationsDOI

Topics & Concepts

MilestoneKRASTargeted therapyDrug approvalCancer drugsMedicineLung cancerFirst lineDrugOncologyCancer researchCancerInternal medicinePharmacologyHistoryColorectal cancerArchaeologyAdvanced Breast Cancer TherapiesBiochemical and Molecular ResearchEnzyme function and inhibition
Oncologists greet Lumakras: the world’s first KRAS inhibitor | Litcius